It is vital that any company doing business in Europe be aware of existing antitrust provisions, and perhaps especially important for those in the life sciences. This presentation gives a general overview of EU antitrust law, and highlights those areas of particular relevance to medical device and pharmaceutical companies. The presentation places added emphasis on identifying special areas of risk, such as agreements restricting competition, information sharing between competitors, distribution agreements and abuse of market-dominating positions. Our speakers will also discuss when you should seek legal assistance, and how to behave in the event of dawn raids.
Complying with EU Antitrust Laws is being presented by Marc Besen & Dr. Christian Mayer, Partner & Associate, Clifford Chance and airs on Tuesday, March 10th, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
Showing posts with label law. Show all posts
Showing posts with label law. Show all posts
Thursday, January 29, 2009
Wednesday, January 21, 2009
Global Patent Standards
Is your patent adequately protected in all of the markets where you do business? Are you sure about that?
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs Tuesday, March 24, 2009. For more details or to register for this event, please visit our site at www.fxconferences.com
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs Tuesday, March 24, 2009. For more details or to register for this event, please visit our site at www.fxconferences.com
Tuesday, January 20, 2009
FCPA Compliance Strategies for Medical Device & Pharma Companies
The Foreign Corrupt Practices Act (FCPA) has had a major impact on the way companies conduct business abroad. A U.S. anti-corruption law jointly enforced by the Department of Justice and the Securities and Exchange Commission, its main provisions deal with improper payments to foreign officials and questionable accounting practices used to hide them. Violating the FCPA can result in both criminal and civil penalties, and the requirements are complex, applying to both companies in the U.S. and foreign-based companies subject to U.S. securities laws. Past enforcement actions have crossed industry boundaries and included the pharmaceutical industry. Lately, there has been an increase in FCPA enforcement activity in the medical device industry as well.
In this audio conference, our speakers combine their experience with real-world case studies to provide a clear background on the FCPA requirements and enforcement trends, along with practical compliance strategies to keep device and pharma companies from running afoul of the law.
FCPA Compliance Strategies for Medical Device & Pharma Companies is being presented by Bethany Hills & Michelle Merola, with Hodgson Russ LLP and airs Wednesday, April 1, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
In this audio conference, our speakers combine their experience with real-world case studies to provide a clear background on the FCPA requirements and enforcement trends, along with practical compliance strategies to keep device and pharma companies from running afoul of the law.
FCPA Compliance Strategies for Medical Device & Pharma Companies is being presented by Bethany Hills & Michelle Merola, with Hodgson Russ LLP and airs Wednesday, April 1, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
Subscribe to:
Posts (Atom)